Rebecca Morris, Sara Rosenbaum, Colleen Grogan, Meredith Rhodes, Christina Andrews
{"title":"医疗补助管理式护理如何满足阿片类药物使用障碍受益人的需求?深入了解合同设计。","authors":"Rebecca Morris, Sara Rosenbaum, Colleen Grogan, Meredith Rhodes, Christina Andrews","doi":"10.1017/amj.2023.35","DOIUrl":null,"url":null,"abstract":"<p><p>Many people who experience opioid use disorder rely on Medicaid. The high penetration of managed care systems into Medicaid raises the importance of understanding states' expectations regarding coverage, access to care, and health system performance and effectively elevates agreements between states and plans into blueprints for coverage and care. Federal law broadly regulates these structured agreements while leaving a high degree of discretion to states and plans. In this study, researchers reviewed the provisions of 15 state Medicaid managed care contract related to substance use disorder (SUD) treatment to identify whether certain elements of SUD treatment were a stated expectation and the extent to which the details of those expectations varied across states in ways that ultimately could affect evaluation of performance and health outcomes. We found that while all states include SUD treatment as a stated contract expectation, discussions around coverage of specific services and nationally recognized guidelines varied. These variations reflect key state choices regarding how much deference to afford their plans in coverage design and plan administration and reveal important differences in purchasing expectations that could carry implications for efforts to examine similarities and differences in access, quality, and health outcomes within managed care across the states.</p>","PeriodicalId":7680,"journal":{"name":"American Journal of Law & Medicine","volume":"49 2-3","pages":"339-348"},"PeriodicalIF":0.5000,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11185417/pdf/","citationCount":"0","resultStr":"{\"title\":\"How Does Medicaid Managed Care Address the Needs of Beneficiaries with Opioid Use Disorders? A Deep Dive into Contract Design.\",\"authors\":\"Rebecca Morris, Sara Rosenbaum, Colleen Grogan, Meredith Rhodes, Christina Andrews\",\"doi\":\"10.1017/amj.2023.35\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Many people who experience opioid use disorder rely on Medicaid. The high penetration of managed care systems into Medicaid raises the importance of understanding states' expectations regarding coverage, access to care, and health system performance and effectively elevates agreements between states and plans into blueprints for coverage and care. Federal law broadly regulates these structured agreements while leaving a high degree of discretion to states and plans. In this study, researchers reviewed the provisions of 15 state Medicaid managed care contract related to substance use disorder (SUD) treatment to identify whether certain elements of SUD treatment were a stated expectation and the extent to which the details of those expectations varied across states in ways that ultimately could affect evaluation of performance and health outcomes. We found that while all states include SUD treatment as a stated contract expectation, discussions around coverage of specific services and nationally recognized guidelines varied. These variations reflect key state choices regarding how much deference to afford their plans in coverage design and plan administration and reveal important differences in purchasing expectations that could carry implications for efforts to examine similarities and differences in access, quality, and health outcomes within managed care across the states.</p>\",\"PeriodicalId\":7680,\"journal\":{\"name\":\"American Journal of Law & Medicine\",\"volume\":\"49 2-3\",\"pages\":\"339-348\"},\"PeriodicalIF\":0.5000,\"publicationDate\":\"2023-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11185417/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American Journal of Law & Medicine\",\"FirstCategoryId\":\"90\",\"ListUrlMain\":\"https://doi.org/10.1017/amj.2023.35\",\"RegionNum\":4,\"RegionCategory\":\"社会学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/2/12 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"LAW\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Law & Medicine","FirstCategoryId":"90","ListUrlMain":"https://doi.org/10.1017/amj.2023.35","RegionNum":4,"RegionCategory":"社会学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/2/12 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"LAW","Score":null,"Total":0}
引用次数: 0
摘要
许多患有阿片类药物使用障碍的人都依靠医疗补助计划(Medicaid)。管理式医疗系统在医疗补助计划中的高度渗透提高了了解各州对覆盖范围、获得医疗服务和医疗系统绩效的期望的重要性,并有效地将各州与计划之间的协议提升为覆盖范围和医疗服务的蓝图。联邦法律对这些结构化协议进行了广泛的规范,同时也给各州和计划留出了很大的自由裁量权。在本研究中,研究人员审查了 15 个州的医疗补助管理性医疗合同中与药物使用障碍(SUD)治疗相关的条款,以确定某些 SUD 治疗要素是否是既定的期望,以及这些期望的细节在各州之间的差异程度,这些差异最终可能会影响绩效和健康结果的评估。我们发现,虽然所有州都将 SUD 治疗作为合同中的一项明确要求,但围绕具体服务的覆盖范围和国家认可的指导方针的讨论却各不相同。这些差异反映了各州在承保设计和计划管理方面对其计划的尊重程度的关键选择,并揭示了购买预期的重要差异,这些差异可能会对研究各州管理性医疗在获取、质量和健康结果方面的异同产生影响。
How Does Medicaid Managed Care Address the Needs of Beneficiaries with Opioid Use Disorders? A Deep Dive into Contract Design.
Many people who experience opioid use disorder rely on Medicaid. The high penetration of managed care systems into Medicaid raises the importance of understanding states' expectations regarding coverage, access to care, and health system performance and effectively elevates agreements between states and plans into blueprints for coverage and care. Federal law broadly regulates these structured agreements while leaving a high degree of discretion to states and plans. In this study, researchers reviewed the provisions of 15 state Medicaid managed care contract related to substance use disorder (SUD) treatment to identify whether certain elements of SUD treatment were a stated expectation and the extent to which the details of those expectations varied across states in ways that ultimately could affect evaluation of performance and health outcomes. We found that while all states include SUD treatment as a stated contract expectation, discussions around coverage of specific services and nationally recognized guidelines varied. These variations reflect key state choices regarding how much deference to afford their plans in coverage design and plan administration and reveal important differences in purchasing expectations that could carry implications for efforts to examine similarities and differences in access, quality, and health outcomes within managed care across the states.
期刊介绍:
desde Enero 2004 Último Numero: Octubre 2008 AJLM will solicit blind comments from expert peer reviewers, including faculty members of our editorial board, as well as from other preeminent health law and public policy academics and professionals from across the country and around the world.